IRLAB Therapeutics
IRLAB A · Nasdaq Stockholm
Public Market Listing
IRLAB ANasdaq Stockholm
Live quotes, historical charts, and market capitalization for IRLAB Therapeutics are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(3 total)
3Total Assets
0Approved
0Phase 3 / Filed
3Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
Mesdopetam (IRL790)No recent activity | Phase 2 | D3Small molecule | Parkinson's Disease |
| Phase 2 | 5-HT/norepinephrineSmall molecule | Parkinson's Disease | |
| Phase 1/2 | Undisclosed / early pipelineSmall molecule | Parkinson's Disease |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.